bookmark

Does Erythropoietin, Used for Anemia in Cancer Patients, Ultimately Lead to Poorer Survival Rates?

http://www.nature.com/modpathol/journal/v18/n3/full/3800288a.html

Description

Diverse nonhematopoietic biological effects of the cytokine erythropoietin shows that it promotes angiogenesis. Recombinant human erythropoietin therapy in prostate cancer will be studied...

Preview

Users

Comments and Reviewsshow / hide

Please log in to take part in the discussion (add own reviews or comments).

BibSonomy